雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Outcome of intravitreal ranibizumab for treatment-naïve age-related macular degeneration:a collaborative study by three hospitals of Tokyo Medical University Setsuko Kawakami 1 , Masahiro Miura 2 , Naomichi Katai 3 , Yoshihiro Wakabayashi 1 , Satoko Nagase 2 , Daisuke Muramatsu 1 , Tsuyoshi Agawa 1 , Keisuke Kimura 1 , Kazuhiko Umazume 1 , Takuya Iwasaki 2 , Hiroshi Goto 1 1Dept of Ophthalmol,Tokyo Med Univ 2Dept of Ophthalmol,Tokyo Med Univ Ibaraki Med Cent 3Dept of Ophthalmol,Tokyo Med Univ Hachioji Med Cent pp.1259-1264
Published Date 2011/8/15
DOI https://doi.org/10.11477/mf.1410103787
  • Abstract
  • Look Inside
  • Reference

Abstract. Purpose:To report the outcome of intravitreal ranibizumab for exudative age-related macular degeneration(AMD)by 3 hospitals of Tokyo Medical University. Cases:This prospective study was made on 104 eyes of 103 cases. The series comprised 78 male and 26 female eyes. The age ranged from 51 to 96 years,average 75 years. Treatment was performed in accordance to a protocol regarding type of CNV and initial visual acuity. Cases were followed up for 6 months. Visual acuity was evaluated as logMAR. Change by 0.3 or more was regarded as significant. Results:Averaged visual acuity improved significantly 3 and 6 months after treatment(each:p<0.01). Visual acuity improved in 20% and remained the same in 90%. Visual acuity after 3 and 6 months improved significantly in eyes with classic AMD and polypoid choroidal vasculopathy. Conclusion:Visual acuity improved or was maintained 3 and 6 months after intravitreal ranibizumab performed in accordance to a unified protocol.


Copyright © 2011, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1882-1308 印刷版ISSN 0370-5579 医学書院

関連文献

もっと見る

文献を共有